340 related articles for article (PubMed ID: 15475572)
1. Receptor endocytosis counteracts the development of opioid tolerance.
Koch T; Widera A; Bartzsch K; Schulz S; Brandenburg LO; Wundrack N; Beyer A; Grecksch G; Höllt V
Mol Pharmacol; 2005 Jan; 67(1):280-7. PubMed ID: 15475572
[TBL] [Abstract][Full Text] [Related]
2. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
3. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
4. mu-opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2.
Koch T; Seifert A; Wu DF; Rankovic M; Kraus J; Börner C; Brandenburg LO; Schröder H; Höllt V
J Neurochem; 2009 Aug; 110(4):1288-96. PubMed ID: 19519662
[TBL] [Abstract][Full Text] [Related]
5. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
6. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
[TBL] [Abstract][Full Text] [Related]
7. Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain.
Chaipatikul V; Loh HH; Law PY
J Pharmacol Exp Ther; 2003 Jun; 305(3):909-18. PubMed ID: 12626655
[TBL] [Abstract][Full Text] [Related]
8. Role of receptor internalization in opioid tolerance and dependence.
Koch T; Höllt V
Pharmacol Ther; 2008 Feb; 117(2):199-206. PubMed ID: 18076994
[TBL] [Abstract][Full Text] [Related]
9. Chronic morphine treatment increases stimulatory beta-2 adrenoceptor signaling in A431 cells stably expressing the mu opioid receptor.
Ammer H; Schulz R
J Pharmacol Exp Ther; 1997 Jan; 280(1):512-20. PubMed ID: 8996236
[TBL] [Abstract][Full Text] [Related]
10. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
11. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
[TBL] [Abstract][Full Text] [Related]
12. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
Xu H; Lu YF; Rothman RB
Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
[TBL] [Abstract][Full Text] [Related]
13. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling.
Wagner EJ; Rønnekleiv OK; Kelly MJ
J Pharmacol Exp Ther; 1998 Jun; 285(3):1266-73. PubMed ID: 9618432
[TBL] [Abstract][Full Text] [Related]
15. The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence.
Martini L; Whistler JL
Curr Opin Neurobiol; 2007 Oct; 17(5):556-64. PubMed ID: 18068348
[TBL] [Abstract][Full Text] [Related]
16. The biochemical analysis of methadone modulation on morphine-induced tolerance and dependence in the rat brain.
He L; Whistler JL
Pharmacology; 2007; 79(4):193-202. PubMed ID: 17356311
[TBL] [Abstract][Full Text] [Related]
17. Involvement of kappa opioid receptors in the inhibition of receptor desensitization and PKC activation induced by repeated morphine treatment.
Hamabe W; Yamane H; Harada S; Tokuyama S
J Pharm Pharmacol; 2008 Sep; 60(9):1183-8. PubMed ID: 18718122
[TBL] [Abstract][Full Text] [Related]
18. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
19. Effect of agmatine on DAMGO-induced mu-opioid receptor down-regulation and internalization via activation of IRAS, a candidate for imidazoline I(1) receptor.
Gao Y; Li F; Wu N; Su RB; Liu Y; Lu XQ; Liu Y; Li J
Eur J Pharmacol; 2008 Dec; 599(1-3):18-23. PubMed ID: 18845140
[TBL] [Abstract][Full Text] [Related]
20. An opiate cocktail that reduces morphine tolerance and dependence.
He L; Whistler JL
Curr Biol; 2005 Jun; 15(11):1028-33. PubMed ID: 15936273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
